Komboglyze 2.5 mg

KOMBOGLYZE 2.5 MG tablets contain saxagliptin hydrochloride, a diabetes medication used to control blood sugar levels. This oral tablet is manufactured by AstraZeneca Canada Inc. and is commonly prescribed as part of a broader diabetes management plan.

KOMBOGLYZE 2.5 MG tablets are primarily used to manage type 2 diabetes in adults. Saxagliptin works by increasing the levels of incretin hormones, which help the pancreas release insulin in response to food intake. This medication is often used alongside diet and exercise to improve glycemic control. People often ask, 'What is saxagliptin used for?' and the answer is that it is used to help manage blood sugar levels in people with type 2 diabetes.

Common effects of KOMBOGLYZE 2.5 MG tablets may include headache, upper respiratory tract infection, and nasopharyngitis. Some users may also experience gastrointestinal issues such as nausea or diarrhea. These effects vary among individuals and are not experienced by everyone who takes the medication.

KOMBOGLYZE 2.5 MG tablets should be handled with care, especially by individuals with a history of kidney problems or pancreatitis. It is important to follow the advice of a healthcare provider regarding the use of this medication. Always store the tablets in a cool, dry place away from direct sunlight.

KOMBOGLYZE 2.5 MG tablets may interact with certain medications, including those metabolized by the liver's CYP3A4 enzyme. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider, as it may affect blood sugar levels.